1. Rogers J. McCance and Huether's Pathophysiology: The Biologic Basis for Disease in Adults and Children. 9th ed. St. Louis, MO: Mosby; 2023.
3. Mitchell R. Pocket Companion to Robbins & Coltran Pathologic Basis of Disease. 8th ed. St. Louis, MO: Elsevier; 2011.
4. Nowak T. Pathophysiology: Concepts and Applications for Health Care Professionals. 3rd ed. New York, NY: McGraw-Hill Science; 2003.
5. Hall JE. Hall ME.Guyton and Hall Textbook of Medical Physiology (Guyton Physiology). 14th ed. St. Louis, MO: Elsevier; 2020.
7. Brashers VL. Clinical Applications of Pathophysiology: Assessment, Diagnostic Reasoning and Management. 2nd ed. St. Louis, MO: Mosby; 2012.
11. Price SA. Pathophysiology: Clinical Concepts of Disease Processes. 7th ed. St. Louis, MO: Mosby; 2014.
12. Lawrence J. Gallstones, Gallbladder Disease and Surgery. Nashville, TN: J Lawrence Publishers: 2013.
14. DiPiro J, Yee GC, Haines ST, et al. DiPiro's Pharmacotherapy: A Pathophysiologic Approach. 12th ed. New York, NY: McGraw Hill; 2023.
16. Talley NJ, Linder KD. Practical Gastroenterology and Hepatology: Liver and Biliary Disease. New York, NY: Wiley: 2010.
18. Buttaro TM. Primary Care: Interprofessional Collaborative Practice. 6th ed. St. Louis, MO: Elsevier; 2020.
19. Ehrman JK, Gordon PM, Visich PS, Keteyian SJ. Clinical Exercise Physiology. New York, NY: Human Kinetics; 2018.
20. Ball J, Dains JE, Flynn JA, Solomon BS, Stewart RW. Seidel's Guide to Physical Examination: An Interprofessional Approach. 10th ed. St. Louis, MO: Mosby; 2023.
22. Mladěnka P, Macáková K, Kujovská Krčmová L, et al. Vitamin K: sources, physiological role, kinetics, deficiency, detection, therapeutic use, and toxicity. Nutrition Reviews. 2021;80(4):677-698.
25. Lingas EC. Hematological abnormalities in cirrhosis: a narrative review. Cureus. 2023;15(5):e39239.
26. Gulankick M, Myers J. Nursing Care Plans: Diagnoses, Interventions, and Outcomes. 8th ed. St. Louis, MO: Elsevier; 2018.
27. Gulankick M, Myers J. Nursing Care Plans: Diagnoses, Interventions, and Outcomes. 10th ed. St. Louis, MO: Elsevier; 2022.
29. Willyard CE, Kalathil SC. Nuclear medicine liver-spleen test. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023.
30. Mousa OY, Kamath PS. A history of the assessment of liver performance. Clin Liver Dis (Hoboken). 2021;18(Suppl 1):28-48.
32. Van Dam J. Endoscopic Approach to the Patient with Biliary Tract Disease. St. Louis, MO: Elsevier Health Sciences: 2013.
33. National Institute of Diabetes and Digesting and Kidney Diseases. Endoscopic Retrograde Cholangiopancreatography (ERCP). Available at https://www.niddk.nih.gov/health-information/diagnostic-tests/endoscopic-retrograde-cholangiopancreatography. Last accessed June 17, 2024.
34. Young M, Collier SA, Mehta D. Percutaneous transhepatic cholangiography. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2024.
35. Boyd A, Cain O, Chauhan A, Webb GJ. Medical liver biopsy: background, indications, procedure and histopathology. Frontline Gastroenterol. 2020;11(1):40-47.
37. Ladwig GB, Ackley BJ, Beth M, Martinez-Kratz MR, Zanotti M. Mosby's Guide to Nursing Diagnosis. St. Louis, MO: Elsevier; 2020.
38. Masudi T, Capitelli-McMahon H, Anwar S. Acute pain management in symptomatic cholelithiasis. World J Gastrointest Surg. 2016;8(10):713-718.
39. Portincasa P, Molina-Molina E, Garruti G, Wang DQ. Critical care aspects of gallstone disease. J Crit Care Med (Targu Mures). 2019;5(1):6-18.
40. Zerwekh J. Mosby's Pharmacology Mnemory NoteCards: Visual, Mnemonic, and Memory Aids for Nurses. 3rd ed. New York, NY: Mosby; 2013.
41. Ford SM. Roach's Introductory Clinical Pharmacology. Philadelphia, PA: Lippincott Williams & Wilkins; 2017.
42. Mikkelsen ACD, Thomsen KL, Vilstrup H, Aagaard NK. Hypokalaemia: an active contributor to hepatic encephalopathy? Metab Brain Dis. 2023;38(5):1765-1768.
43. Ullah H, H Shabana, Mohamed Akl Rady, et al. Hypokalemia as a responsible factor related with the severity of hepatic encephalopathy: a wide multination cross-sectional study. Annals of Medicine and Surgery. 2023;85(6):2427-2431.
44. Liu J, Lkhagva E, Chung HJ, Kim HJ, Hong ST. The pharmabiotic approach to treat hyperammonemia. Nutrients. 2018;10(2):140.
45. Iqbal U, Jadeja RN, Khara HS, Khurana S. A comprehensive review evaluating the impact of protein source (vegetarian vs. meat based) in hepatic encephalopathy. Nutrients. 2021;13(2):370.
47. Wagner KH, Shiels RG, Lang CA, Seyed Khoei N, Bulmer AC. Diagnostic criteria and contributors to Gilbert's syndrome. Critical Reviews in Clinical Laboratory Sciences. 2018;55(2):129-139.
48. Spinner NB, Loomes KM, Krantz ID, Gilbert MA. Alagille syndrome. In: Adam MP, Feldman J, Mirzaa GM, et al. (eds). GeneReviews. Seattle, WA: University of Washington, Seattle; 2024.
51. Sanyal AJ, Manns MP. Yakim and Bogris Hepatology. St. Louis, MO: Elsevier Health Sciences; 2011.
52. Diaz-Soto MP, Garcia-Tsao G. Management of varices and variceal hemorrhage in liver cirrhosis: a recent update. Therap Adv Gastroenterol. 2022;15:17562848221101712.
54. American College of Surgeons. Posterior Rectus Sheath Hernia. Available at https://www.facs.org/for-medical-professionals/news-publications/journals/case-reviews/issues/v3n5/aru-minnesota/. Last accessed June 18, 2024.
56. Pallio S, Melita G, Shahini E, et al. Diagnosis and management of esophagogastric varices. Diagnostics. 2023;13(6):1031.
57. The Society of Gastroenterology Nurses and Associates. Medications. Available at https://www.sgna.org/Practice-Resources/GI-Nurse-Sedation/Medications. Last accessed June 18, 2024.
58. Yu Y, Qi SL, Zhang Y. Role of combined propofol and sufentanil anesthesia in endoscopic injection sclerotherapy for esophageal varices. World J Gastroenterol. 2017;23(44):7875-7880.
59. Ignatavicius D, Workman L. Medical-Surgical Nursing: Concepts for Interprofessional Collaborative Care. 10th ed. St. Louis, MO: Elsevier; 2021.
60. Bauldoff G, Gubrud-Howe PM, Carno MA, Lemone P. LeMone & Burke's Medical-Surgical Nursing: Clinical Reasoning in Patient Care. 7th ed. New York, NY: Pearson Education; 2020.
61. Aithal GP, Palaniyappan N, China L, et al. Guidelines on the management of ascites in cirrhosis. Gut. 2021;70:9-29.
62. Fabrellas N, Künzler-Heule P, Olofson A, Jack K, Carol M. Nursing care for patients with cirrhosis. Journal of Hepatology. 2023;79(1):218-225.
63. Trivella J, John BV, Levy C. Primary biliary cholangitis: Epidemiology, prognosis, and treatment. Hepatol Commun. 2023;7(6):e0179.
64. Younossi ZM. Practical Management of Liver Diseases. Cambridge: Cambridge University Press; 2010.
65. Sargent S. Liver Disease: An Essential Guide for Nurses and Health Care Professionals. New York: NY: Wiley; 2011.
66. Ludwig DR, Anderson MA, Itani M, Sharbidre KG, Lalwani N, Paspulati RM. Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis. Abdom Radiol (NY). 2023;48(1):151-165.
67. Gudnason HO, Björnsson ES. Secondary sclerosing cholangitis in critically ill patients: current perspectives. Clin Exp Gastroenterol. 2017;10:105-111.
68. Patel R, Mueller M. Alcoholic liver disease. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023.
69. Osna NA, Donohue TM Jr, Kharbanda KK. Alcoholic liver disease: pathogenesis and current management. Alcohol Res. 2017;38(2):147-161.
70. Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966-1986.
71. Akter S. Non-alcoholic fatty liver disease and steatohepatitis: risk factors and pathophysiology. Middle East J Dig Dis. 2022;14(2):167-181.
72. Petroni ML, Brodosi L, Bugianesi E, Marchesini G. Management of non-alcoholic fatty liver disease. BMJ. 2021;372:m4747.
73. Liu C, Sun X, Peng J, Yu H, Lu J, Feng Y. Association between dietary vitamin A intake from different sources and non-alcoholic fatty liver disease among adults. Scientific Reports. 2024;14(1):1851.
74. Mantovani A, Dalbeni A. Treatments for NAFLD: state of art. International Journal of Molecular Sciences. 2021;22(5):2350.
76. Friedman LS, Martin P. Handbook of Liver Disease. Philadelphia, PA: Elsevier Health Sciences; 2017.
77. Masia R, Misdraji J. Liver and bile duct infections. Diagnostic Pathology of Infectious Disease. 2018;1:272-322.
78. National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Clinical Course and Diagnosis of Drug Induced Liver Disease. Available at https://www.ncbi.nlm.nih.gov/books/NBK548733/pdf/Bookshelf_NBK548733.pdf. Last accessed June 19, 2024.
81. National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Halothane. Available at https://www.ncbi.nlm.nih.gov/books/NBK548151/pdf/Bookshelf_NBK548151.pdf. Last accessed June 19, 2024.
82. Radu-Ionita F, Pyrsopoulos NT, Jinga M, Tintoiu IC, Sun Z, Bontas E. Liver Diseases: A Multidisciplinary Textbook. New York, NY: Springer International Publishing; 2020.
83. Sanyal AJ, Boyer TD, Terrault N, Lindor KD. Zakim and Boyer's Hepatology: A Textbook of Liver Disease. St. Louis, MO: Elsevier; 2018.
84. Tepper ML, Gully PR. Viral hepatitis: know your D, E, F, and G. Can Med Assoc J. 1997;156:1735-1738.
85. Bhattarai N, Stapleton, JT. GB virus C: the good boy virus? Trends Microbiol. 2012;20(3):124-130.
86. World Health Organization. Hepatitis A. Available at https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/hep-a#. Last accessed August 7, 2024.
87. Centers for Disease Control and Prevention. Disease Burden from Hepatitis A, B, and C in the United States. Available at https://www.cdc.gov/hepatitis/PDFs/disease_burden.pdf. Last accessed August 7, 2024.
88. U.S. Department of Health and Human Services. Viral Hepatitis National Strategic Plan Overview. Available at https://www.hhs.gov/hepatitis/viral-hepatitis-national-strategic-plan/national-viral-hepatitis-action-plan-overview/index.html. Last accessed August 7, 2024.
89. Lin YN, Chou JW, Cheng KS, Peng CY, Jeng LB, Chiang IP. Treatment of fulminant autoimmune hepatitis: corticosteroid therapy or liver transplantation? A case report and literature review. Gastroenterology Res. 2011;4(5):231-235.
90. Redfield RR, Schuchat A, Richards CL, et al. Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR. 2020;69(5):1-38.
91. Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Washington, DC: Public Health Foundation; 2015.
92. Technical Bulletin: PURELL Healthcare Surface Disinfectant. Available at https://cdn2.hubspot.net/hubfs/43298/PURELL%20Healthcare%20Surface%20Disinfectant%20Technical%20Bulletin.pdf . Last accessed August 7, 2024.
93. Kampf G. Efficacy of ethanol against viruses in hand disinfection. J Hosp Infect. 2018;98(4):331-338.
94. Centers for Disease Control and Prevention. Hepatitis B Vaccination of Infants, Children, and Adolescents. Available at https:// www.cdc.gov/hepatitis/hbv/vaccchildren.htm. Last accessed August 7, 2024.
95. Baird M. Manual of Critical Care Nursing: Interprofessional Collaborative Management. St. Louis, MO: Elsevier; 2023.
96. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 Hepatitis B Guidance. Hepatology. 2018;67(4):1560-1599.
97. Gewirtzman A, Bobrick L, Conner K, Tyring SK. Epidemiology of sexually transmitted infections. In: Gross G, Tyring SK (eds). Sexually Transmitted Infections and Sexually Transmitted Diseases. Berlin: Springer; 2011.
98. Thio CL, Hawkins C. Hepatitis B virus and hepatitis delta virus. In: Bennett JE, Dolin R, Blaser MJ (eds). Mandell, Douglas and Bennett's Infectious Disease Essentials. 1st ed. Philadelphia, PA: Elsevier; 2016: 198-201.
99. Centers for Disease Control and Prevention. Hepatitis B Information. Frequently Asked Questions for Health Professionals. Available at https://www.cdc.gov/hepatitis/hbv/hbvfaq.htm. Last accessed August 7, 2024.
100. Sood GK. Acute Liver Failure. Available at https://emedicine.medscape.com/article/177354-overview. Last accessed August 7, 2024.
101. LexiDrug. Available at https://online.lexi.com. Last accessed August 7, 2024.
102. U.S. Food and Drug Administration. BLA Approval Letter. Available at https://www.fda.gov/media/108828/download?attachment. Last accessed August 7, 2024.
103. Centers for Disease Control and Prevention. ACIP Presentation Slides: November 2–3, 2021 Meeting. Available at https://www.cdc.gov/vaccines/acip/meetings/slides-2021-11-2-3.html. Last accessed August 7, 2024.
104. Centers for Disease Control and Prevention. Hepatitis C Questions and Answers for Health Professionals. Available at https://www.cdc.gov/hepatitis/HCV/HCVfaq.htm. Last accessed August 7, 2024.
105. Centers for Disease Control and Prevention. CDC Urging Dialysis Providers and Facilities to Assess and Improve Infection Control Practices to Stop Hepatitis C Virus Transmission in Patients Undergoing Hemodialysis. Available at https://emergency.cdc.gov/han/han00386.asp. Last accessed August 7, 2024.
106. Cox R. Hepatitis C (Hep C, HCV). Available at https://www.emedicinehealth.com/hepatitis_c/article_em.htm. Last accessed August 7, 2024.
107. Strader DB. Coinfection with HIV and hepatitis C virus in injection drug users and minority populations. Clin Infect Dis. 2005;41(1):S7-S13.
108. Centers for Disease Control and Prevention. Hepatitis C Surveillance 2021: Hepatitis C Figures and Tables. Available at https:// www.cdc.gov/hepatitis/statistics/2021surveillance/hepatitis-c.htm#anchor_03753. Last accessed August 7, 2024.
109. Bennett NJ. Pediatric Hepatitis C Clinical Presentation. Available at https://emedicine.medscape.com/article/964761-clinical. Last accessed August 7, 2024.
110. Alberti A, Benvegnù L. Viral infections of the liver. In: Rodés J, Benhamou JP, Blei A, REichen J, Rizzetto M (eds). Textbook of Hepatology: From Basic Science to Clinical Practice. 3rd ed. Oxford: Blackwell Publishing; 2007.
111. Poynard T, Bedossa P, Opolon, P. Natural history of liver fibrosis progression in patients with chronic hepatiti. C. Lancet. 1997;349(9055):825-832.
113. Lab Tests Online. Hepatitis C Test. Available at https://www.testing.com/tests/hepatitis-c-test/. Last accessed August 7, 2024.
114. Kohli A, Shaffer A, Sherman A, Kottilil S. Treatment of hepatitis C: a systematic review. JAMA. 2014;312(6):631-640.
115. American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C. Available at https://www.hcvguidelines.org/sites/default/ files/full-guidance-pdf/AASLD-IDSA_HCVGuidance_December_19_2023.pdf.6 Last accessed August 7, 2024.
116. Ioannou GN, Feld JJ. What are the benefits of a sustained virologic response to direct-acting antiviral therapy for hepatitis C virus infection? Gastroenterology. 2019;156(2):446-460.
117. University of Washington. Hepatitis C Online: Host Factors that May Impact Response to Therapy. Available at https://www.hepatitisc.uw.edu/custom/evaluation-treatment/treatment-goals-predicting-response/5. Last accessed July 9, 2024.
118. Bhattacharya D, Aronsohn A, Price J, Lo Re V III. Hepatitis C guidance 2023 update: American Association for the Study of Liver Diseases – Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection. Clin Infect Dis. 2023; [Epub ahead of print].
119. Samji NS. Viral Hepatitis. Available at https://emedicine.medscape.com/article/775507-overview. Last accessed August 7, 2024.
120. World Health Organization. Hepatitis B. Available at https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Last accessed August 7, 2024.
121. Samji NS. Viral Hepatitis Clinical Presentation. Available at https://emedicine.medscape.com/article/775507-clinical. Last accessed August 7, 2024.
122. Wedemyer H, Yurdaydìn C, Dalekos GN, et al. Peginterferon plus adefovir versus drug alone for hepatitis delta. N Engl J Med. 2011;364(4):322-331.
123. Cassity S. Hepatitis in Pregnancy. Available at https://emedicine.medscape.com/article/1562368-overview. Last accessed August 7, 2024.
124. World Health Organization. Hepatitis E. Available at https://www.who.int/news-room/fact-sheets/detail/hepatitis-e. Last accessed August 7, 2024.
125. World Health Organization. Hepatitis A. Available at https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/hep-a#. Last accessed August 7, 2024.
126. Lin YN, Chou JW, Cheng KS, Peng CY, Jeng LB, Chiang IP. Treatment of fulminant autoimmune hepatitis: corticosteroid therapy or liver transplantation? A case report and literature review. Gastroenterology Res. 2011;4(5):231-235.
127. Redfield RR, Schuchat A, Richards CL, et al. Prevention of hepatitis A virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR. 2020;69(5):1-38.
128. Mencarini L, Vestito A, Zagari RM, Montagnani M. The Diagnosis and Treatment of Acute Cholecystitis: A Comprehensive Narrative Review for a Practical Approach. J Clin Med. 2024;13(9):2695.
130. Foglia B, Turato C, Cannito S. Hepatocellular carcinoma: latest research in pathogenesis, detection and treatment. Int J Mol Sci. 2023;24(15):12224.
131. Feldman M, Friedman LS, Brandt LJ. Gastrointestinal and Liver Disease. New York, NY: J Lawrence Publishers; 2013.
134. Charach L, Zusmanovitch L, Charach G. Hepatocellular carcinoma. Part 2: clinical presentation and diagnosis. EMJ Hepatology. 2017;1:81-88.
135. National Cancer Institute. Primary Liver Cancer Treatment: Health Professional Version. Available at https://www.cancer.gov/types/liver/hp/adult-liver-treatment-pdq. Last accessed August 6, 2024.
136. Qurashi M, Vithayathil M, Khan SA. Epidemiology of cholangiocarcinoma. European Journal of Surgical Oncology. 2023;1:107064.
137. National Cancer Institute. Bile Duct Cancer (Cholangiocarcinoma) Treatment: Health Professional Version. Available at https:// www.cancer.gov/types/liver/hp/bile-duct-treatment-pdq. Last accessed August 6, 2024.
138. National Cancer Institute. Gallbladder Cancer Treatment: Health Professional Version. Available at https://www.cancer.gov/types/gallbladder/hp/gallbladder-treatment-pdq. Last accessed August 6, 2024.
141. Tanaja J, Lopez RA, Meer JM. Cholelithiasis. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023.
142. Cariati A. Gallstone classification in Western countries. Indian J Surg. 2015;77(Suppl 2):376-380.
143. Burns GP. Disorders of the Pancreas: Current Issues in Diagnosis and Management. New York, NY: McGraw-Hill Professional Publishing; 2012.
144. National Institute of Diabetes and Digestive and Kidney Diseases. Eating, Diet, & Nutrition for Gallstones. Available at https:// www.niddk.nih.gov/health-information/digestive-diseases/gallstones/eating-diet-nutrition. Last accessed August 7, 2024.
145. Norris TL. Porth's Pathophysiology: Concepts of Altered Health States. 10th ed. New York, NY: Wolters Kluwer; 2019.
146. Dahiya DS, Facciorusso A, Chandan S, et al. Understanding evidence-based clinical practice guidelines for cholelithiasis 2021. Hepatobiliary Surgery and Nutrition. 2024;13(2):352-355.
147. American Liver Foundation. Liver Transplant. Available at https://liverfoundation.org/liver-diseases/treatment/liver-transplant. Last accessed August 7, 2024.
148. Luu L. Liver Transplants. Available at https://emedicine.medscape.com/article/776313-overview. Last accessed August 7, 2024.
149. Chung RT, Dienstag JL. Liver transplantation. In: Fauci AS, Braunwals E, Isselbacher K, Wilson J, Martin J, Kasper DL, Hauser SL, Longo D (eds). Harrison's Principles of Internal Medicine. 19th ed. New York, NY: McGraw-Hill; 2015.
150. Kwong AJ, Ebel NH, Kim WR, et al. OPTN/SRTR 2020 annual data report: liver. Am J Transplant. 2022;(Suppl 2):204-309.
151. Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol. 2011;54(6):1297-1306.
152. Lucey MR. New Trends in Liver Transplantation. Conference Summary, the American Association for the Study of Liver Diseases 50th Annual Meeting. Dallas, TX. November 5–9, 1999.
153. Chan C, Fan ST, Lo CM, et al. A decade of right liver adult-to-adult living donor liver transplantation: the recipient mid-term outcomes. Ann Surg. 2008:248(3):411-419.
154. Organ Procurement and Transplantation Network. New National Liver and Intestinal Organ Transplant System in Effect. Available at https://optn.transplant.hrsa.gov/news/new-national-liver-and-intestinal-organ-transplant-system-in-effect/. Last accessed August 7, 2024.
155. Rosen HR, Martin P. Hepatitis B and C in the liver transplant recipient. Semin Liver Dis. 2000;20:465-480.
156. Hanto DW. A 50-year-old man with hepatitis C and cirrhosis needing liver transplantation. JAMA. 2003;290(24):3238-3246.
157. Merck Manual Professional Version. Liver Transplantation. Available at https://www.merckmanuals.com/professional/immunology-allergic-disorders/transplantation/liver-transplantation. Last accessed August 7, 2024.
1. Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020;71(1):306-333. Available at https://journals.lww.com/hep/fulltext/2020/01000/diagnosis_and_treatment_of_alcohol_associated.25.aspx. Last accessed August 12, 2024.
2. European Association for the Study of the Liver, European Association for the Study of Diabetes, and European Association for the Study of Obesity. EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J Hepatol. 2024:S0168-8278(24):00329-5. Available at https://www.journal-of-hepatology.eu/article/S0168-8278(24)00329-5/fulltext. Last accessed August 12, 2024.
3. U.S. Preventive Services Task Force. Screening for Hepatitis B Virus Infection in Adolescents and Adults. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening. Last accessed August 12, 2024.
4. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):261-283. Available at https://journals.lww.com/hep/pages/articleviewer.aspx?year=2018&issue=04000&article=00034&type=Fulltext. Last accessed August 12, 2024.
5. U.S. Preventive Services Task Force. Hepatitis C Virus Infection in Adolescents and Adults: Screening. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening. Last accessed August 12, 2024.
6. Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020;72(2):671-722. Available at https://journals.lww.com/hep/fulltext/2020/08000/diagnosis_and_management_of_autoimmune_hepatitis.24.aspx. Last accessed August 12, 2024.
7. Singal AG, Llovet JM, Yarchoan M, et al. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023;78(6):1922-1965. Available at https://journals.lww.com/hep/fulltext/2023/12000/aasld_practice_guidance_on_prevention,_diagnosis,.27.aspx. Last accessed August 12, 2024.
Mention of commercial products does not indicate endorsement.